GlassScriptPhysician profile
Bronwyn Wilke
NPI 1841277761
$2,817.01
in general payments reported to CMS, 2019-2025
16 companies · $626 in 2025
The $626 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $66.63 · 2021: $33.10 · 2022: $72.88 · 2023: $528 · 2024: $1,354 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,686 · Travel and Lodging: $823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,685.66 |
| Travel and Lodging | $823.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novus Surgical Consultants | $767.08 | 2024-2025 | |
| Arthrex, INC. | $455.20 | 2024 | |
| Treace Medical Concepts, INC. | $384.80 | 2022-2025 | |
| Stryker Corporation | $333.03 | 2023-2025 | Augment Injectable, T2, Ortholoc 2 Lapifuse |
| Averitas Pharma INC. | $218.73 | 2023-2024 | Qutenza |
| Abbott Laboratories | $142.24 | 2023 | Proclaim |
| Alexion Pharmaceuticals, INC. | $124.99 | 2023 | |
| Organogenesis INC. | $96.73 | 2020-2025 | Cygnus Dual, Puraply Wound Matrix |
| Merck Sharp & Dohme LLC | $93.61 | 2019 | |
| Smith+Nephew, INC. | $41.72 | 2023-2024 | Collagenase Santyl, Regranex |
| Heron Therapeutics, INC. | $33.10 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $31.73 | 2023 | Seglentis |
| Grt US Holding, INC. | $29.15 | 2022 | |
| Arteriocyte Medical Systems, INC. | $25.38 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $22.81 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $16.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bronwyn Wilke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.